Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer-Reference-Cited by-同舟云学术

Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer

Published:2024-01-22 Issue:3 Volume:27 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Wang Ying¹,Yu Botao²,Qu Mengyuan³,Liu Fengjuan⁴,Wu Xiao⁵

Affiliation:

1. Department of Nosocomial Infection, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong 266042, P.R. China

2. Department of Emergency Medicine, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong 266042, P.R. China

3. Department of Radiophysics, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong 266042, P.R. China

4. Ward for Phase I Clinical Trial, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong 266042, P.R. China

5. Department of Pulmonary and Critical Care Medicine, Affiliated Qingdao Central Hospital of Qingdao University, Qingdao Cancer Hospital, Qingdao, Shandong 266042, P.R. China

Publisher

Spandidos Publications

Reference30 articles.

1. Preneoplastic lesions of the lung;Greenberg;Respir Res,2002

2. Epidemiology of Lung Cancer;Mao;Surg Oncol Clin N Am,2016

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J Clin,2021

4. Lung cancer: Biology and treatment options;Lemjabbar-Alaoui;Biochim Biophys Acta,2015

5. Five-Year Survival Among Stage IIIA Lung Cancer Patients Receiving Two Different Treatment Modalities;Bilfinger;Med Sci Monit,2016